HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong

Clinical trial NCT07530198 · RECRUITING

Trial details

NCT number: NCT07530198
Sponsor: Immuno Cure Holding (HK) Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Human Immunodeficiency Virus I Infection

Start date: 2026-03-30
Primary completion: 2027-03-31
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.